00730nas a2200217   4500000000100000008004100001100001800042700001300060700001500073700004100088700001600129700001100145700001300156700001600169700001300185700001900198245026000217300002100477490000800498050000600506       2004                            d1 aSchumacher H.1 aPogue J.1 aSleight P.1 aONTARGET and TRANSCEND Investigators1 aHilbrich L.1 aTeo K.1 aYusuf S.1 aMookadam F.1 aRamos B.1 aAnderson Craig00aRationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination, in high risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telm  a52-61.[IF 3.649]0 v148  aY